Clinical trial
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
NCT00067119 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 1, 2003
- Completion date
- January 31, 2008
- Enrollment
- 649 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
kidney failure